Theraclion SA (ALTHE.PA) Stock Price

€0.69 2.3%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    5
  • Fundamental

    2
  • Technical

    8

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Theraclion SA, AI stock picks, stock alerts and much more.

Sign up

ALTHE.PA AI Stock Analysis

AI stock analysis for ALTHE.PA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Theraclion SA (ALTHE.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Theraclion SA (ALTHE.PA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Theraclion SA (ALTHE.PA), currently trading at €0.69, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About ALTHE.PA

LSE
  • Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system.

  • Symbol

    ALTHE.PA

  • Market

    EURONEXT

  • Industry

    Medical - Devices

  • Market Cap

    32.5M

Similar Stocks

News

No news articles.

ALTHE.PA Alternative Data

Web Traffic

Theraclion SA receives an estimated 1310 monthly visitors to theraclion.com.

  • Web Traffic

    1310

  • Change from Previous Month

    60.9%

  • 3 Month Change

    27.9%

  • YoY Change

    27.9%

Youtube Subscribers

Theraclion SA has 442 subscribers on its main Youtube channel, up by 0.7% over the last month.

  • Youtube Subscribers

    442

  • Daily Change

    0%

  • 1 Month Change

    0.7%

  • 3 Month Change

    1.1%

LinkedIn Employees

According to LinkedIn, Theraclion SA has 38 employees, down by -2.6% over the last month.

  • LinkedIn Employees

    38

  • Daily Change

    2.6%

  • 1 Month Change

    2.6%

  • 3 Month Change

    0%

Instagram Followers

Theraclion SA has 394 Instagram Followers on its main Instagram account, up by 0.8% over the last month.

  • Instagram Followers

    394

  • Daily Change

    0.3%

  • 1 Month Change

    0.8%

  • 3 Month Change

    5.6%

Business Outlook

According to employee reviews, the business outlook among employees at Theraclion SA is 13 out of 100 (very bearish).

  • Business Outlook

    13

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Twitter Followers

Theraclion SA has 86 Twitter Followers on its main Twitter (also known as X) account.

  • Twitter Followers

    86

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Theraclion SA was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

Theraclion SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

ALTHE.PA Financials

ALTHE.PA Key Metrics
  • Total Revenue

    €388.4K

  • Net Income

    -€3.4M

  • Earnings per Share

    -€0.0732

  • Free cash flow

    -€1.6M

  • EBITDA

    -€2.9M

  • EBITDA Ratio

    -7.45283

  • Total Assets

    €14.9M

ALTHE.PA 2-year Revenue & Income
ALTHE.PA 2-year Free Cash Flow

ALTHE.PA Technicals

ALTHE.PA SMA
ALTHE.PA RSI

FAQ

What's the current price of Theraclion SA (ALTHE.PA) Stock?
The price of an Theraclion SA (ALTHE.PA) share is €0.69.

What's the market cap of Theraclion SA?
The current market cap of Theraclion SA is 32.5M.

Should I buy or sell ALTHE.PA?
Theraclion SA shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Theraclion SA is better viewed as a hold or accumulate position while waiting for further developments.

Is Theraclion SA a good investment?
The current analysis of Theraclion SA's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Theraclion SA's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Theraclion SA (ALTHE.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Theraclion SA stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Theraclion SA (ALTHE.PA) that investors often compare it to?
Theraclion SA (ALTHE.PA) is often compared to similar stocks such as Euroapi S.A., Novacyt S.A., Euromedis Groupe, Median Technologies SA and Diagnostic Medical Systems S.A..

What is the forecast for Theraclion SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Theraclion SA's stock price to be around €0.687 in 2026. Starting from the current price of €0.69, this represents a 0.4% change in price, indicating a neutral outlook for the stock.

How to buy Theraclion SA (ALTHE.PA) Stock?
Theraclion SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Theraclion SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.